A New Dawn for Challenges to FDA Actions? Kisor and the Tenuous Vitality of Administrative Deference

Published date13 November 2019
Subject MatterFDA,SCOTUS,Judicial Review,Administrative Procedure Act,Auer Deference,Chevron Deference,Administrative Interpretation,Pharmaceutical Industry,Constitutional Challenges,Reasonable Interpretations,Administrative Agencies,Kisor v Wilkie
AuthorDouglas Hallward-Driemeier,Greg Levine,Emerson Siegle,Beth Weinman,Rebecca Williams
Law FirmRopes & Gray LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT